Most Popular Stories
- Gloom for the pharma industry, yes. Doom? No
- FDA talks, but doctors don't necessarily listen
- Astellas scores highest in Japanese M&A bout
- As blockbuster drugs fade, so does TV advertising
- Women's own cells could blast breast cancer
- Botox delivers for Allergan, Dr. Reddy's sees big profit increase during quarter
- FDA commish counters industry critics on expert conflict rules
- Scoring winners and losers in Japan pharma M&A bout
- Idenix gets good news on hep C trial, but can't compete with Gilead
- AstraZeneca's R&D chief in China lays out $100M strategy
- Gilead shares surge as hep C drug scores a cure for big patient population
Webinars
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
Featured Jobs
-
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US -
Associate Director, Reimbursement Strategy and Trends
Xcenda - San Francisco preferred or Charlotte, NC or Remote -
Manager, Field Outsourcing
Xcenda - New Mexico, Kansas, Lubbock TX and Omaha -
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA -
Manager, Business Development
Clinical Resource Network - Chicago, IL
Events
- Wharton Health Care Business Conference
Feb 16-17 — Philadelphia, PA - CALBIO2012: Driven By Patients - Marriott Marquis
March 8-9 — San Francisco, CA - Connect, Collaborate, & Innovate: MassBio Annual Meeting
March 26-27 — Cambridge, MA - BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Failing to Establish and Maintain CAPA Systems? Your Company Could Be At Risk.
- API in Capsule: Common "First in Man" approaches vs. The Lost Art of Formulation Development
- The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics
- Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?
- Pharma 2.0: Heading Toward Social Media Marketing
- Biosimilars: A Physician Perspective
Biography for John Carroll
John D. Carroll is a biotech analyst with 32 years of prize-winning experience in journalism. Appointed editor of FierceBiotech in 2003, he has covered genomics, biotechnology, healthcare and other business topics for Managed Care, American Banker, Small Times, and Local Business.com, He has also contributed stories from Central America and Ireland to the Dallas Morning News and Time and wrote for the Houston Press and other leading publications. He spent six years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at the Kansas City Star & Times. He enjoys hiking, traveling and spending time with his family. Carroll is based in Vermont and Texas and can be reached at john@fiercemarkets.com. Follow @JohnCFierce on Twitter.
Articles by John Carroll
- February 3, 2012
- February 3, 2012
- February 3, 2012
- February 2, 2012
- February 2, 2012
- February 1, 2012
- February 1, 2012
- February 1, 2012
- February 1, 2012
- February 1, 2012
- January 31, 2012
- January 30, 2012
- January 30, 2012
- January 30, 2012
- January 30, 2012
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
